Skip to main content

Table 5 Ordinary Least Squares model weighted in two stages with instrumental variables incorporated for therapeutic adherence

From: Estimating the effectiveness of self-help groups on the adoption of secondary preventive measures by people living with HIV in Central America, 2012

Variables

Categories

 

1st stage: Intervention vs. control

2nd stage: adherence

   

Coeff

CI

Coeff

CI

Country

El Salvador

 

1.000

  

1.000

  

Belize

 

0.467*

0.410

0.524

−0.085

−0.439

0.269

Costa Rica

 

−0.046

−0.115

0.022

−0.059

− 0.121

0.002

Guatemala

 

0.435*

0.382

0.487

−0.035

− 0.356

0.286

Honduras

 

0.249*

0.195

0.303

−0.072

− 0.268

0.123

Panama

 

0.422*

0.370

0.475

0.258

−0.062

0.580

Age (years)

16–24

 

1.000

  

1.000

  

25–44

 

−0.055*

−0.097

− 0.012

0.026

− 0.033

0.086

45–59

 

−0.072*

−0.123

− 0.021

0.019

− 0.052

0.0918

≥60

 

−0.066

−0.143

0.009

0.004

−0.080

0.089

Schooling

None

 

1.000

  

1.000

  

Literate

 

−0.025

−0.126

0.074

0.037

−0.039

0.115

6 years

 

−0.061*

−0.106

− 0.017

0.044

− 0.014

0.104

12 years

 

−0.104*

−0.153

− 0.056

0.070

− 0.012

0.153

≥16 years

 

−0.044

−0.107

0.017

0.022

−0.046

0.090

Sex

Female

 

1.000

  

1.000

  

Male

 

0.028

−0.005

0.062

−0.017

−0.054

0.020

Sexual orientation

Heterosexual

 

1.000

  

1.00

  

Bisexual

 

0.056

−0.005

0.119

−0.013

−0.090

0.064

Homosexual

 

0.013

−0.032

0.059

−0.015

−0.067

0.036

Currently in a stable relationship

No

 

1.000

  

1.000

  

Yes

 

0.019

−0.012

0.050

−0.020

−0.050

0.009

Average

Monthly income

0–2581 USD

 

−8.720

−0.000

0.000

−8.870

−0.000

0.000

Family support

No

 

1.000

  

1.000

  

Yes

 

0.036*

0.001

0.071

−0.032

−0.072

0.007

Economic dependents

No

 

1.000

  

1.000

  

Yes

 

−0.006

−0.039

0.027

0.035*

0.005

0.066

History of pulmonary tuberculosis

No

 

1.000

  

1.000

  

Yes

 

0.015

−0.024

0.056

0.081*

0.038

0.125

Received counseling when tested for HIV

No

 

1.000

  

1.000

  

Yes

 

−0.005

−0.049

0.039

−0.057*

− 0.099

−0.015

History of drug use

No

 

1.000

  

1.000

  

Yes

 

−0.034

−0.090

0.021

0.136*

0.069

0.202

Future time perspective (scale)

        

1

0.198*

0.099

0.297

−0.166

−0.369

0.036

2

0.052

−0.149

0.254

−0.162

−0.343

0.017

3

−0.053

−0.256

0.148

−0.040

− 0.239

0.159

4

−0.063

−0.213

0.086

−0.021

− 0.193

0.150

5

−0.116*

−0.224

− 0.007

−0.103

− 0.257

0.050

6

−0.057

−0.132

0.017

−0.048

− 0.175

0.077

7

−0.033

−0.106

0.038

−0.083

− 0.201

0.034

 

8

−0.016

−0.092

0.059

−0.085

− 0.203

0.032

 

9

−0.113*

−0.193

− 0.033

−0.080

− 0.225

0.063

 

10

0.198*

0.099

0.297

−0.166

−0.369

0.036

Distance to SHG

Km (Euclidean)

 

−0.001*

−0.001

− 0.000

–

–

–

Distance to SHG - squared Euclidean

Km (Euclidean)

 

4.560*

1.410

7.720

–

–

–

Participation

Control

 

–

–

–

1.000

  

Intervention

 

–

–

–

0.128

−0.629

0.885

  1. Source: prepared by the author based on data from the following project: Elaboration of the risk profile of people living with HIV in the beneficiary countries of the REDCA+ Regional Program; *p < 0.05; overidentification test: p = 0.282; endogeneity test: p = 0.756; weakness test: p = 0.012 (F = 3.37)